iTSCM cells also exhibit decreased expression of the T-cell inhibitory receptors programmed cell death-1 (PD-1) and cytotoxic-T-lymphocyte-associated protein 4 (CTLA-4), allowing for enhanced survival and activation in the tumor microenvironment (23). This evidence concerns the gene CTLA4 and neoplasm.